Global Oncolytic Virus Therapy Competitive Landscape Professional Research Report 2024

Global Oncolytic Virus Therapy Competitive Landscape Professional Research Report 2024

Research Summary

Oncolytic virus therapy, also known as virotherapy, is a type of cancer treatment that utilizes genetically engineered or naturally occurring viruses to selectively target and destroy cancer cells. The viruses used in oncolytic virus therapy are designed to replicate within cancer cells, causing their death while leaving healthy cells unharmed. This therapy takes advantage of the natural ability of certain viruses to infect and replicate within cells. Oncolytic viruses can be modified to enhance their tumor targeting, safety, and anticancer effects. When administered to patients, these viruses selectively infect and replicate within cancer cells, leading to tumor cell lysis and the release of tumor-associated antigens. This process stimulates an immune response, promoting the recognition and destruction of both infected cancer cells and non-infected cancer cells. Oncolytic virus therapy has shown promise in preclinical and clinical trials for various types of cancer and may be used as a standalone treatment or in combination with other cancer therapies, such as chemotherapy, radiation, or immunotherapy. The field of oncolytic virus therapy continues to evolve, with ongoing research and clinical trials aiming to optimize the therapeutic potential and broaden the utility of this innovative treatment approach.

According to DIResearch's in-depth investigation and research, the global Oncolytic Virus Therapy market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Oncolytic Virus Therapy include Amgen, Oncolytics Biotech, Viralytics, Oncolys BioPharma, Transgene SA, Targovax, PsiOxus Therapeutics, SillaJenBiotherapeutics, Genelux Corporation, Sorrento Therapeutics, Lokon Pharma, Cold Genesys, TILT Biotherapeutics, Vyriad etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Oncolytic Virus Therapy. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Oncolytic Virus Therapy market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Oncolytic Virus Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oncolytic Virus Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Oncolytic Virus Therapy Include:

Amgen

Oncolytics Biotech

Viralytics

Oncolys BioPharma

Transgene SA

Targovax

PsiOxus Therapeutics

SillaJenBiotherapeutics

Genelux Corporation

Sorrento Therapeutics

Lokon Pharma

Cold Genesys

TILT Biotherapeutics

Vyriad

Oncolytic Virus Therapy Product Segment Include:

HSV-based Oncolytic Viruses

Adenoviruses-based Oncolytic Viruses

Vaccinia Virus-based Oncolytic Viruses

Vesicular Stomatitis Virus-based Oncolytic Viruses

Newcastle Disease Virus-based Oncolytic Viruses

Oncolytic Virus Therapy Product Application Include:

Melanoma

Prostate Cancer

Breast Cancer

Ovarian Cancer

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Oncolytic Virus Therapy Industry PESTEL Analysis

Chapter 3: Global Oncolytic Virus Therapy Industry Porter’s Five Forces Analysis

Chapter 4: Global Oncolytic Virus Therapy Major Regional Market Size and Forecast Analysis

Chapter 5: Global Oncolytic Virus Therapy Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Oncolytic Virus Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Oncolytic Virus Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Oncolytic Virus Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Oncolytic Virus Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Oncolytic Virus Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Oncolytic Virus Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Oncolytic Virus Therapy Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources